Arcturus therapeutics to attend the following investor conferences

San diego--(business wire)--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global, late-stage messenger rna medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the company will participate in the following investor conferences. jefferies cell and genetic medicine summit (attending) thursday – friday, september 29 – 30, 2022 cantor neurology &am
ARCT Ratings Summary
ARCT Quant Ranking